Aducanumab Alternatives – What You Can Use Today

If you or a loved one has heard about Aducanumab and worries about its cost or side effects, you’re not alone. Many people look for other ways to slow memory loss without dealing with expensive infusions. Below is a quick guide to the most common alternatives that are easier to get, usually cheaper, and backed by real‑world use.

Oral Meds That Work Without Injections

Donepezil (Aricept) stays on the market because it helps many patients keep daily tasks a bit easier. You take one pill every day, and most doctors start with a low dose to avoid stomach upset. If you feel dizzy or nauseous, let your doctor know – they can adjust the amount.

Rivastigmine (Exelon) is another pill that works on the same brain pathways as Aducanumab but without an IV line. Some people prefer a patch instead of a tablet because the skin stick releases medication slowly and reduces stomach issues.

Galantamine (Razadyne) fits in between Donepezil and Rivastigmine. It’s taken twice a day, and many users say it helps with focus more than memory alone. As with any drug, watch for headaches or trouble sleeping and report them.

If you’re looking for something newer, Lecanemab (Leqembi) just received approval and works similarly to Aducanumab but may have a lower risk of brain swelling. It’s still an infusion, yet the dosage schedule is shorter – once every two weeks instead of monthly.

Lifestyle & Emerging Therapies

Medication isn’t the only answer. Regular exercise, especially brisk walking or swimming, can boost blood flow to the brain and slow decline. Aim for at least 30 minutes most days; even short walks add up.

Nutrition matters too. A diet rich in leafy greens, berries, fish, and olive oil – often called the Mediterranean plan – supplies antioxidants that protect neurons. Swapping sugary snacks for nuts or avocado can make a noticeable difference over months.

Some clinics now offer repetitive transcranial magnetic stimulation (rTMS). It’s a non‑invasive headset that gently stimulates brain areas involved in memory. Early reports show modest improvement, and there are no needles involved.

Finally, keep an eye on clinical trials for drugs like Donanemab or anti‑tau antibodies. These studies often let participants try cutting‑edge treatments at reduced cost while contributing to research.

The bottom line is that you have several paths besides Aducanumab. Talk with your doctor about which oral pill fits your health profile, add regular exercise and a brain‑friendly diet, and ask about any new non‑invasive options they know of. Making these changes now can give you more control over the disease and avoid the hassle of monthly infusions.